Pursley James 4

4 · Hinge Health, Inc. · Filed Mar 24, 2026

AI-generated summary of this filing

Updated Mar 24, 2026

Hinge Health (HNGE) President James Pursley Sells Shares

What Happened

James Pursley, President of Hinge Health (HNGE), sold a total of 15,000 shares in three open-market transactions on 2026-03-23, generating aggregate proceeds of $633,928. The individual sales were 2,256 shares at $41.21 ($92,976); 9,838 shares at $42.36 ($416,709); and 2,906 shares at $42.75 ($124,243). These transactions are sales (S), not purchases.

Key Details

Transaction date: 2026-03-23; Form 4 filed: 2026-03-24 (appears timely).
Per-line prices and proceeds:
- 2,256 shares @ $41.21 = $92,976 (footnote F2: weighted avg; prices ranged $40.66–$41.62).
- 9,838 shares @ $42.36 = $416,709 (footnote F3: weighted avg; prices ranged $41.66–$42.65).
- 2,906 shares @ $42.75 = $124,243 (footnote F4: weighted avg; prices ranged $42.66–$42.86).
Combined weighted average price ≈ $42.26 per share; total proceeds $633,928.
Shares owned after the transaction: not specified in this Form 4.
Notable footnote: F1 states these sales were effected pursuant to a Rule 10b5-1 trading plan adopted June 13, 2025 — indicating the trades were made under a pre-established plan. Footnotes F2–F4 note weighted-average pricing and provide price ranges; the filer offers to provide exact per-price sale counts on request.

Context

These are outright sales (not option exercises or awards). Because they were executed under a 10b5-1 plan, the trades were likely pre-scheduled; this reduces (but does not eliminate) inference about timing or insider intent. For retail investors, purchases generally carry stronger signals than routine sales; this filing documents routine liquidity under a trading plan rather than an acquisition.

Form 4

Period: 2026-03-23

President

Transactions

Sale
Class A Common Stock
[F1][F2]
2026-03-23$41.21/sh−2,256$92,976→ 744,848 total
Sale
Class A Common Stock
[F1][F3]
2026-03-23$42.36/sh−9,838$416,709→ 735,010 total
Sale
Class A Common Stock
[F1][F4]
2026-03-23$42.75/sh−2,906$124,243→ 732,104 total

Footnotes (4)

[F1]The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025.
[F2]Represents the weighted average sale price. The lowest price at which shares were sold was $40.66 and the highest price at which shares were sold was $41.62. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
[F3]Represents the weighted average sale price. The lowest price at which shares were sold was $41.66 and the highest price at which shares were sold was $42.65. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
[F4]Represents the weighted average sale price. The lowest price at which shares were sold was $42.66 and the highest price at which shares were sold was $42.86. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Signature

/s/ James Budge, Attorney-in-Fact|2026-03-24

1 file